SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (1921)9/30/1997 2:29:00 AM
From: Henry Niman   of 6136
 
John, Earlier today I came over to the thread because I had read the article in thestreet and found several posters asking about the price decline and the analysts downgrade. I suggested that they read the article. As fas as thestreet is concerned, I think that they run stories that will be read. I suspect that someone told them about the abstract and they noted it as an exclusive. I haven't been following the meeting that closely, but I do look for Biotech news in many places and I didn't read about the abstract anywhere except in thestreet. Later the abstract was cited as one of the reasons for one or more downgrades.

I don't think that thestreet will publish a series of aricles on AGPH or the conference. The article that they published has many caveates. Like posts on this board, such information is a usefull starting point.

AGPH has done a good job of capturing a fair share of the PI market. Finding conspiracies everywhere will not be a benefit to the stock or other posters.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News